Teachers Retirement System of The State of Kentucky cut its stake in shares of Encompass Health Co. (NYSE:EHC – Free Report) by 22.2% in the 3rd quarter, HoldingsChannel reports. The firm owned 47,006 shares of the company’s stock after selling 13,450 shares during the period. Teachers Retirement System of The State of Kentucky’s holdings in Encompass Health were worth $4,543,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Los Angeles Capital Management LLC lifted its holdings in shares of Encompass Health by 532.4% during the 3rd quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company’s stock worth $4,860,000 after acquiring an additional 42,338 shares during the last quarter. Pathstone Holdings LLC boosted its holdings in shares of Encompass Health by 54.5% in the 3rd quarter. Pathstone Holdings LLC now owns 21,022 shares of the company’s stock worth $2,032,000 after purchasing an additional 7,412 shares in the last quarter. Deerfield Management Company L.P. Series C bought a new position in shares of Encompass Health during the 2nd quarter valued at about $541,000. Meeder Asset Management Inc. raised its holdings in shares of Encompass Health by 43.8% during the 3rd quarter. Meeder Asset Management Inc. now owns 66,405 shares of the company’s stock valued at $6,417,000 after buying an additional 20,242 shares in the last quarter. Finally, Thrivent Financial for Lutherans lifted its position in Encompass Health by 26.0% in the 3rd quarter. Thrivent Financial for Lutherans now owns 760,496 shares of the company’s stock worth $73,494,000 after buying an additional 156,938 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.
Analyst Upgrades and Downgrades
EHC has been the topic of a number of recent research reports. Barclays increased their price target on shares of Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Truist Financial reiterated a “buy” rating and issued a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. UBS Group upped their price target on shares of Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, September 25th. Royal Bank of Canada lifted their price objective on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. Finally, KeyCorp increased their target price on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Nine equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, Encompass Health currently has a consensus rating of “Buy” and a consensus price target of $107.11.
Encompass Health Stock Performance
Encompass Health stock opened at $98.19 on Friday. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The firm has a market cap of $9.89 billion, a P/E ratio of 23.72, a P/E/G ratio of 1.34 and a beta of 0.86. Encompass Health Co. has a 1-year low of $65.33 and a 1-year high of $104.55. The firm has a 50-day moving average of $99.35 and a 200-day moving average of $92.49.
Encompass Health (NYSE:EHC – Get Free Report) last released its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.09. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The business had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.33 billion. During the same quarter last year, the business posted $0.86 EPS. The business’s revenue was up 11.9% on a year-over-year basis. Sell-side analysts expect that Encompass Health Co. will post 4.29 EPS for the current year.
Encompass Health Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be issued a $0.17 dividend. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $0.68 annualized dividend and a yield of 0.69%. Encompass Health’s dividend payout ratio (DPR) is presently 16.43%.
Encompass Health Company Profile
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Further Reading
- Five stocks we like better than Encompass Health
- 5 Top Rated Dividend Stocks to Consider
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Trading Stocks: RSI and Why it’s Useful
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHC – Free Report).
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.